MysteryVibe key facts
as of Oct 2026- Developer of FDA-IIa medical devices designed to address genito-pelvic pain, period pain, arousal disorder and erectile dysfunction.
- MysteryVibe is valued at approximately $41.4M as of Oct 2026 (last reported valuation).
- It has raised $21.6M; the latest was Later Stage VC ($5.3M) in Sep 2025.
- Notable investors include Elkstone, Richard Fearn, Alexander Cowell, Rameet Chawla, Ahan Investment — 22 tracked in total.
- Status: Privately Held (backing).
MysteryVibe's last reported valuation, Sep 2025. Nothing priced has surfaced since.
- ·The complete investor list: 22 names
- ·Watch MysteryVibe: the Monday email on marks, rounds and moves
MysteryVibe funding rounds
No funding rounds for MysteryVibe are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs MysteryVibe
22+Membership and data by Private Market View
MysteryVibe valuation
MysteryVibe's last reported valuation was $41.4 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.
MysteryVibe investors
22 investors are on record for MysteryVibe, including Elkstone, Richard Fearn, Alexander Cowell and Rameet Chawla.
About MysteryVibe
Developer of FDA-IIa medical devices designed to address genito-pelvic pain, period pain, arousal disorder and erectile dysfunction. The company's USP is a patented technology that adapts to the user's body and delivers targeted vibrations, enabling users to elevate sexual health with purposeful innovation and actionable knowledge without any medicines and side effects.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Puttenham, United Kingdom
- Founded
- 2014
- Employees
- 21
- Website
- mysteryvibe.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.